Emerald Advisers LLC lowered its position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 48.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,296 shares of the semiconductor company's stock after selling 4,891 shares during the period. Emerald Advisers LLC's holdings in Silicon Laboratories were worth $658,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Raymond James Financial Inc. purchased a new position in shares of Silicon Laboratories during the fourth quarter valued at approximately $14,252,000. Arizona State Retirement System lifted its position in shares of Silicon Laboratories by 1.8% in the 4th quarter. Arizona State Retirement System now owns 9,360 shares of the semiconductor company's stock worth $1,163,000 after purchasing an additional 167 shares during the period. Franklin Resources Inc. boosted its stake in shares of Silicon Laboratories by 1.9% during the 3rd quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company's stock valued at $27,001,000 after purchasing an additional 4,278 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in shares of Silicon Laboratories during the third quarter valued at about $7,408,000. Finally, Intech Investment Management LLC raised its stake in Silicon Laboratories by 82.9% in the third quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company's stock worth $1,484,000 after buying an additional 5,818 shares in the last quarter.
Analyst Upgrades and Downgrades
SLAB has been the topic of several research reports. Needham & Company LLC reaffirmed a "buy" rating and set a $150.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. StockNews.com cut shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a research report on Thursday. Barclays raised their target price on shares of Silicon Laboratories from $75.00 to $120.00 and gave the company an "equal weight" rating in a research note on Friday, January 17th. Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a report on Wednesday, March 12th. Finally, Susquehanna assumed coverage on shares of Silicon Laboratories in a research note on Tuesday, December 17th. They set a "neutral" rating and a $130.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, Silicon Laboratories presently has an average rating of "Hold" and an average target price of $136.20.
Read Our Latest Analysis on Silicon Laboratories
Insider Activity at Silicon Laboratories
In other Silicon Laboratories news, Director Navdeep S. Sooch sold 2,360 shares of the firm's stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the sale, the director now owns 400,567 shares in the company, valued at approximately $59,684,483. This trade represents a 0.59 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William G. Bock sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now owns 31,115 shares of the company's stock, valued at approximately $4,649,514.45. The trade was a 3.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,360 shares of company stock worth $782,610. Corporate insiders own 1.72% of the company's stock.
Silicon Laboratories Trading Down 5.5 %
NASDAQ SLAB traded down $6.54 during trading hours on Friday, hitting $113.03. 340,644 shares of the company's stock traded hands, compared to its average volume of 314,853. Silicon Laboratories Inc. has a 52 week low of $94.00 and a 52 week high of $160.00. The firm has a market capitalization of $3.67 billion, a P/E ratio of -19.03 and a beta of 1.15. The business's fifty day moving average price is $136.65 and its two-hundred day moving average price is $123.53.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The business had revenue of $166.25 million for the quarter, compared to analysts' expectations of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company's revenue was up 91.4% compared to the same quarter last year. During the same quarter last year, the company posted ($1.19) EPS. On average, sell-side analysts expect that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Further Reading

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report